Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 30184451

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Sep 6
First author
Morschhauser F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Morschhauser F
      type
      Author
    2. name
      Fowler NH
      type
      Author
    3. name
      Feugier P
      type
      Author
    4. name
      Bouabdallah R
      type
      Author
    5. name
      Tilly H
      type
      Author
    6. name
      Palomba ML
      type
      Author
    7. name
      Fruchart C
      type
      Author
    8. name
      Libby EN
      type
      Author
    9. name
      Casasnovas RO
      type
      Author
    10. name
      Flinn IW
      type
      Author
    11. name
      Haioun C
      type
      Author
    12. name
      Maisonneuve H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Morschhauser F
      type
      Author
    2. name
      Fowler NH
      type
      Author
    3. name
      Feugier P
      type
      Author
    4. name
      Bouabdallah R
      type
      Author
    5. name
      Tilly H
      type
      Author
    6. name
      Palomba ML
      type
      Author
    7. name
      Fruchart C
      type
      Author
    8. name
      Libby EN
      type
      Author
    9. name
      Casasnovas RO
      type
      Author
    10. name
      Flinn IW
      type
      Author
    11. name
      Haioun C
      type
      Author
    12. name
      Maisonneuve H
      type
      Author
    bibliography ids
    1. nci-bib-22b36431e0f4a1561f61b0b1
    book metadata
    content sha256
    8f49c788e952723dc78a638cc07f07ce13ffd50f0f1d753d9d34d25439418a07
    document type
    citation
    dois
    1. 10.1056/NEJMoa1805104
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30184451
    immutable id
    pubmed:30184451@8f49c788e952723dc78a638cc07f07ce13ffd50f0f1d753d9d34d25439418a07
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    10
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    934-947
    volume
    379
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30184451
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      e752573e3b323821ddfc05f0e104aa33e55c694c08d46a43e7a61e12fa1e5fba
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Sep 6
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      6. Equivalence Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30184451/
      title
      Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice